A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing LOXO-292 to Platinum-Based and Pemetrexed Therapy with or without Pembrolizumab as Initial Treatment of Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

Project: Research

StatusActive
Effective start/end date27/11/1926/11/24

Keywords

  • clinical trial
  • treatment efficacy
  • phase 3 study